Yu EY, Kolinsky MP, Berry WR, Retz M, et al. Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study. Eur Urol 2022 Apr 6. pii: S0302-2838(22)01665.
PMID: 35397952